Status:
COMPLETED
IF-MCT 16:8: Investigating the Influence of Intermittent Fasting With and Without MCTs in Patients With Drug-resistant Epilepsy
Lead Sponsor:
University Hospital Marburg
Conditions:
Epilepsy
Intermittent Fasting
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The objective of the prospective monocentric pilot trial is to investigate the influence of intermittent fasting with or without a once-daily intake with medium chain triglycerides (MCTs) on the frequ...
Detailed Description
One in three patients suffering epilepsy does not become seizure-free with conventional pharmacotherapy. The chance of seizure freedom with each additional medication is only in the single-digit perce...
Eligibility Criteria
Inclusion
- Subjects able to provide informed consent
- Drug-resistant epilepsy
- At least 3 seizures per month
Exclusion
- Pregnancy
- Breast feeding period
- Metabolic disorder (e.g. diabetes, liver cirrhosis, kidney disease)
- Eating Disorder (e.g. anorexia, bulimia)
- Chronic inflammatory gut disease
- Active cancerous disease
- Antibiotics within the last 3 months
Key Trial Info
Start Date :
July 25 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 31 2025
Estimated Enrollment :
22 Patients enrolled
Trial Details
Trial ID
NCT06013761
Start Date
July 25 2023
End Date
May 31 2025
Last Update
December 4 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Philipps University Marburg, Faculty of Medicine, Department of Neurology, Epilepsy Center
Marburg, Hesse, Germany, Baldingerstr., 35043